Genesco Inc.
NYSE:GCOApparel - Retail
+$1.44 today
- Market cap
- $386.71M
- Beta
- 1.82
- P/E (TTM)
- 19.1
- EPS (TTM)
- $1.89
Volume 0.11M
Average 0.23M
GCO Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Genesco Inc.NYSE: GCO
Stock-Based Compensation · Q1 FY2027 · quarter ended May 2026
Stock-based compensation declines year over year
Q1 FY2027 stock-based compensation of $2.81M fell 6.0% year over year, ahead of the -101.4% change in trailing-twelve-month stock-based compensation. Over 3 fiscal years it compounded at -4.4% a year.
Context
- Stock-based compensation amounted to 0.5% of revenue in FY2026, unchanged from a year earlier.
- Stock-based compensation increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -6.0% holds above the trailing-twelve-month pace of -101.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2026
- 12.24M USD
- Year-over-year change
- -4.9%
- 4-year CAGR
- +7.6%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 12.24M | -4.9% |
| FY2025 | 2025-02-01 | 12.87M | -10.7% |
| FY2024 | 2024-02-03 | 14.4M | +2.7% |
| FY2023 | 2023-01-28 | 14.02M | +53.5% |
| FY2022 | 2022-01-29 | 9.13M | — |
Stock-Based Compensation vs competitors
How GCO compares with its peers on the latest reported figures
- Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -101.4% is the lowest of 11, against a peer median of +45.5%.
- Stock-based compensation amounts to 0.0% of revenue for GCO, versus a peer median of 0.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
EMPDEmpery Digital Inc. | LTM Mar 2026 | $19.52M USD | +5944.3% | — | 4201.0% |
| LTM Dec 2025 | CN¥15.35M CNY | -36.7% | -58.9% | 0.4% | |
| LTM Mar 2026 | $8.4M USD | +52.0% | -30.6% | 1.4% | |
| LTM Apr 2026 | $7.71M USD | -18.8% | +5.0% | 0.6% | |
| LTM Jan 2026 | $6.75M USD | +79.3% | -2.0% | 0.4% | |
| LTM May 2026 | $5.72M USD | +69.0% | +14.0% | 0.7% | |
| LTM Apr 2026 | $5.64M USD | +38.9% | +22.7% | 1.1% | |
| LTM Mar 2026 | $5.23M USD | -15.3% | +0.5% | 0.7% | |
| LTM Mar 2026 | $4.17M USD | -44.6% | -29.0% | 0.6% | |
| LTM Mar 2026 | $3.52M USD | +64.1% | — | 1.2% | |
| LTM May 2026 | $180K USD | -101.4% | -4.4% | 0.0% | |
| Peer median (excluding GCO) | — | +45.5% | -0.7% | 0.7% | |
Competitors are the stored peer set for GCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Feb 2024 | FY2025 Feb 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 114.85M | 71.92M | (16.83M) | (18.89M) | 13.27M |
| Depreciation & Amortization | 42.97M | 42.82M | 49.44M | 52.46M | 53.33M |
| Deferred Income Tax | (18.71M) | (26.39M) | 3.45M | 26.76M | (1.21M) |
| Stock-Based Compensation | 9.13M | 14.02M | 14.4M | 12.87M | 12.24M |
| Change in Working Capital | 107.82M | (269.61M) | 13.66M | 12.01M | 62.67M |
| Accounts Receivables | (8.28M) | (1.08M) | (13.29M) | 4.3M | 9.8M |
| Inventory | 10.83M | (183.58M) | 80.35M | (49.08M) | (1.16M) |
| Accounts Payables | 3.76M | (11.84M) | (27.67M) | 54.33M | (13.18M) |
| Other Working Capital | 101.51M | (73.11M) | (39.02M) | 2.46M | 67.22M |
| Other Non-Cash Items | (16.19M) | 2.37M | 30.67M | 2.68M | 5.46M |
| Operating Cash Flow | 239.87M | (164.88M) | 94.8M | 87.89M | 145.76M |
| Capital Expenditures | (53.91M) | (59.93M) | (60.3M) | (41.13M) | (62.05M) |
| Acquisitions (Net) | (80K) | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 20.09M | 0 | 302K | 1K | 0 |
| Investing Cash Flow | (33.9M) | (59.93M) | (60M) | (41.13M) | (62.05M) |
| Debt Repayment | (19.03M) | 30.05M | (10.6M) | (34.64M) | 566K |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (78.07M) | (77.47M) | (32.03M) | (9.79M) | (12.57M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (5.87M) | 1.89M | (4.96M) | (2.57M) | (1.32M) |
| Financing Cash Flow | (101.17M) | (45.53M) | (47.58M) | (47M) | (13.32M) |
| Effect of Forex Changes | 631K | (2.19M) | (51K) | (900K) | 1.01M |
| Net Change in Cash | 105.43M | (272.54M) | (12.84M) | (1.15M) | 71.4M |
| Free Cash Flow | 185.97M | (224.82M) | 34.49M | 46.75M | 83.71M |
Genesco Inc.
NYSE:GCO
Intrinsic Alpha fair value
Locked
Current Price
$35.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.